Vertex Pharmaceuticals Aktie
397,20
EUR
-2,75
EUR
-0,69
%
467,57
USD
-2,79
USD
-0,59
%
Werbung
Vertex Pharmaceuticals Aktie Analyse
| 14.12.12 | Vertex Pharmaceuticals sell | Goldman Sachs Group Inc. | |
| 05.11.12 | Vertex Pharmaceuticals sell | Goldman Sachs Group Inc. | |
| 04.01.08 | Vertex Pharmaceuticals underperform | Wachovia Sec | |
| 14.12.06 | Vertex Pharmaceuticals sell | Banc of America Sec. | |
| 21.11.05 | Vertex Pharmaceuticals Sell | Banc of America Sec. |
Werbung
Werbung